The Traveler’s Diarrhea Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Traveler’s Diarrhea Treatment market size is estimated to be worth US$ 808.1 million in 2021 and is forecast to a readjusted size of USD 1269.2 million by 2028 with a CAGR of 6.7% during review period. Adult Traveler's Diarrhea accounting for % of the Traveler’s Diarrhea Treatment global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Immunization segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Traveler’s Diarrhea Treatment include Salix Pharmaceuticals, P&G, Johnson & Johnson, Otsuka Pharma, and Valneva, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Traveler’s Diarrhea Treatment market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Immunization
Non-antibiotic Agents
Antibiotics
Anti-Motility Agents
Other
Market segment by Application, can be divided into
Adult Traveler's Diarrhea
Children Traveler's Diarrhea
Market segment by players, this report covers
Salix Pharmaceuticals
P&G
Johnson & Johnson
Otsuka Pharma
Valneva
Shanghai United Cell
PaxVax
Livzon
Immuron
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Traveler’s Diarrhea Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Traveler’s Diarrhea Treatment, with revenue, gross margin and global market share of Traveler’s Diarrhea Treatment from 2019 to 2022.
Chapter 3, the Traveler’s Diarrhea Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Traveler’s Diarrhea Treatment market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Traveler’s Diarrhea Treatment research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Traveler’s Diarrhea Treatment
1.2 Classification of Traveler’s Diarrhea Treatment by Type
1.2.1 Overview: Global Traveler’s Diarrhea Treatment Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Traveler’s Diarrhea Treatment Revenue Market Share by Type in 2021
1.2.3 Immunization
1.2.4 Non-antibiotic Agents
1.2.5 Antibiotics
1.2.6 Anti-Motility Agents
1.2.7 Other
1.3 Global Traveler’s Diarrhea Treatment Market by Application
1.3.1 Overview: Global Traveler’s Diarrhea Treatment Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Adult Traveler's Diarrhea
1.3.3 Children Traveler's Diarrhea
1.4 Global Traveler’s Diarrhea Treatment Market Size & Forecast
1.5 Global Traveler’s Diarrhea Treatment Market Size and Forecast by Region
1.5.1 Global Traveler’s Diarrhea Treatment Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Traveler’s Diarrhea Treatment Market Size by Region, (2017-2022)
1.5.3 North America Traveler’s Diarrhea Treatment Market Size and Prospect (2017-2028)
1.5.4 Europe Traveler’s Diarrhea Treatment Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Traveler’s Diarrhea Treatment Market Size and Prospect (2017-2028)
1.5.6 South America Traveler’s Diarrhea Treatment Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Traveler’s Diarrhea Treatment Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Traveler’s Diarrhea Treatment Market Drivers
1.6.2 Traveler’s Diarrhea Treatment Market Restraints
1.6.3 Traveler’s Diarrhea Treatment Trends Analysis
2 Company Profiles
2.1 Salix Pharmaceuticals
2.1.1 Salix Pharmaceuticals Details
2.1.2 Salix Pharmaceuticals Major Business
2.1.3 Salix Pharmaceuticals Traveler’s Diarrhea Treatment Product and Solutions
2.1.4 Salix Pharmaceuticals Traveler’s Diarrhea Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Salix Pharmaceuticals Recent Developments and Future Plans
2.2 P&G
2.2.1 P&G Details
2.2.2 P&G Major Business
2.2.3 P&G Traveler’s Diarrhea Treatment Product and Solutions
2.2.4 P&G Traveler’s Diarrhea Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 P&G Recent Developments and Future Plans
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Traveler’s Diarrhea Treatment Product and Solutions
2.3.4 Johnson & Johnson Traveler’s Diarrhea Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Johnson & Johnson Recent Developments and Future Plans
2.4 Otsuka Pharma
2.4.1 Otsuka Pharma Details
2.4.2 Otsuka Pharma Major Business
2.4.3 Otsuka Pharma Traveler’s Diarrhea Treatment Product and Solutions
2.4.4 Otsuka Pharma Traveler’s Diarrhea Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Otsuka Pharma Recent Developments and Future Plans
2.5 Valneva
2.5.1 Valneva Details
2.5.2 Valneva Major Business
2.5.3 Valneva Traveler’s Diarrhea Treatment Product and Solutions
2.5.4 Valneva Traveler’s Diarrhea Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Valneva Recent Developments and Future Plans
2.6 Shanghai United Cell
2.6.1 Shanghai United Cell Details
2.6.2 Shanghai United Cell Major Business
2.6.3 Shanghai United Cell Traveler’s Diarrhea Treatment Product and Solutions
2.6.4 Shanghai United Cell Traveler’s Diarrhea Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Shanghai United Cell Recent Developments and Future Plans
2.7 PaxVax
2.7.1 PaxVax Details
2.7.2 PaxVax Major Business
2.7.3 PaxVax Traveler’s Diarrhea Treatment Product and Solutions
2.7.4 PaxVax Traveler’s Diarrhea Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 PaxVax Recent Developments and Future Plans
2.8 Livzon
2.8.1 Livzon Details
2.8.2 Livzon Major Business
2.8.3 Livzon Traveler’s Diarrhea Treatment Product and Solutions
2.8.4 Livzon Traveler’s Diarrhea Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Livzon Recent Developments and Future Plans
2.9 Immuron
2.9.1 Immuron Details
2.9.2 Immuron Major Business
2.9.3 Immuron Traveler’s Diarrhea Treatment Product and Solutions
2.9.4 Immuron Traveler’s Diarrhea Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Immuron Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Traveler’s Diarrhea Treatment Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Traveler’s Diarrhea Treatment Players Market Share in 2021
3.2.2 Top 10 Traveler’s Diarrhea Treatment Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Traveler’s Diarrhea Treatment Players Head Office, Products and Services Provided
3.4 Traveler’s Diarrhea Treatment Mergers & Acquisitions
3.5 Traveler’s Diarrhea Treatment New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Traveler’s Diarrhea Treatment Revenue and Market Share by Type (2017-2022)
4.2 Global Traveler’s Diarrhea Treatment Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Traveler’s Diarrhea Treatment Revenue Market Share by Application (2017-2022)
5.2 Global Traveler’s Diarrhea Treatment Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Traveler’s Diarrhea Treatment Revenue by Type (2017-2028)
6.2 North America Traveler’s Diarrhea Treatment Revenue by Application (2017-2028)
6.3 North America Traveler’s Diarrhea Treatment Market Size by Country
6.3.1 North America Traveler’s Diarrhea Treatment Revenue by Country (2017-2028)
6.3.2 United States Traveler’s Diarrhea Treatment Market Size and Forecast (2017-2028)
6.3.3 Canada Traveler’s Diarrhea Treatment Market Size and Forecast (2017-2028)
6.3.4 Mexico Traveler’s Diarrhea Treatment Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Traveler’s Diarrhea Treatment Revenue by Type (2017-2028)
7.2 Europe Traveler’s Diarrhea Treatment Revenue by Application (2017-2028)
7.3 Europe Traveler’s Diarrhea Treatment Market Size by Country
7.3.1 Europe Traveler’s Diarrhea Treatment Revenue by Country (2017-2028)
7.3.2 Germany Traveler’s Diarrhea Treatment Market Size and Forecast (2017-2028)
7.3.3 France Traveler’s Diarrhea Treatment Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Traveler’s Diarrhea Treatment Market Size and Forecast (2017-2028)
7.3.5 Russia Traveler’s Diarrhea Treatment Market Size and Forecast (2017-2028)
7.3.6 Italy Traveler’s Diarrhea Treatment Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Traveler’s Diarrhea Treatment Revenue by Type (2017-2028)
8.2 Asia-Pacific Traveler’s Diarrhea Treatment Revenue by Application (2017-2028)
8.3 Asia-Pacific Traveler’s Diarrhea Treatment Market Size by Region
8.3.1 Asia-Pacific Traveler’s Diarrhea Treatment Revenue by Region (2017-2028)
8.3.2 China Traveler’s Diarrhea Treatment Market Size and Forecast (2017-2028)
8.3.3 Japan Traveler’s Diarrhea Treatment Market Size and Forecast (2017-2028)
8.3.4 South Korea Traveler’s Diarrhea Treatment Market Size and Forecast (2017-2028)
8.3.5 India Traveler’s Diarrhea Treatment Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Traveler’s Diarrhea Treatment Market Size and Forecast (2017-2028)
8.3.7 Australia Traveler’s Diarrhea Treatment Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Traveler’s Diarrhea Treatment Revenue by Type (2017-2028)
9.2 South America Traveler’s Diarrhea Treatment Revenue by Application (2017-2028)
9.3 South America Traveler’s Diarrhea Treatment Market Size by Country
9.3.1 South America Traveler’s Diarrhea Treatment Revenue by Country (2017-2028)
9.3.2 Brazil Traveler’s Diarrhea Treatment Market Size and Forecast (2017-2028)
9.3.3 Argentina Traveler’s Diarrhea Treatment Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Traveler’s Diarrhea Treatment Revenue by Type (2017-2028)
10.2 Middle East & Africa Traveler’s Diarrhea Treatment Revenue by Application (2017-2028)
10.3 Middle East & Africa Traveler’s Diarrhea Treatment Market Size by Country
10.3.1 Middle East & Africa Traveler’s Diarrhea Treatment Revenue by Country (2017-2028)
10.3.2 Turkey Traveler’s Diarrhea Treatment Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Traveler’s Diarrhea Treatment Market Size and Forecast (2017-2028)
10.3.4 UAE Traveler’s Diarrhea Treatment Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Traveler’s Diarrhea Treatment Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Traveler’s Diarrhea Treatment Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Traveler’s Diarrhea Treatment Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Traveler’s Diarrhea Treatment Revenue (USD Million) by Region (2017-2022)
Table 5. Global Traveler’s Diarrhea Treatment Revenue Market Share by Region (2023-2028)
Table 6. Salix Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 7. Salix Pharmaceuticals Major Business
Table 8. Salix Pharmaceuticals Traveler’s Diarrhea Treatment Product and Solutions
Table 9. Salix Pharmaceuticals Traveler’s Diarrhea Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. P&G Corporate Information, Head Office, and Major Competitors
Table 11. P&G Major Business
Table 12. P&G Traveler’s Diarrhea Treatment Product and Solutions
Table 13. P&G Traveler’s Diarrhea Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 15. Johnson & Johnson Major Business
Table 16. Johnson & Johnson Traveler’s Diarrhea Treatment Product and Solutions
Table 17. Johnson & Johnson Traveler’s Diarrhea Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Otsuka Pharma Corporate Information, Head Office, and Major Competitors
Table 19. Otsuka Pharma Major Business
Table 20. Otsuka Pharma Traveler’s Diarrhea Treatment Product and Solutions
Table 21. Otsuka Pharma Traveler’s Diarrhea Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Valneva Corporate Information, Head Office, and Major Competitors
Table 23. Valneva Major Business
Table 24. Valneva Traveler’s Diarrhea Treatment Product and Solutions
Table 25. Valneva Traveler’s Diarrhea Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Shanghai United Cell Corporate Information, Head Office, and Major Competitors
Table 27. Shanghai United Cell Major Business
Table 28. Shanghai United Cell Traveler’s Diarrhea Treatment Product and Solutions
Table 29. Shanghai United Cell Traveler’s Diarrhea Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. PaxVax Corporate Information, Head Office, and Major Competitors
Table 31. PaxVax Major Business
Table 32. PaxVax Traveler’s Diarrhea Treatment Product and Solutions
Table 33. PaxVax Traveler’s Diarrhea Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Livzon Corporate Information, Head Office, and Major Competitors
Table 35. Livzon Major Business
Table 36. Livzon Traveler’s Diarrhea Treatment Product and Solutions
Table 37. Livzon Traveler’s Diarrhea Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Immuron Corporate Information, Head Office, and Major Competitors
Table 39. Immuron Major Business
Table 40. Immuron Traveler’s Diarrhea Treatment Product and Solutions
Table 41. Immuron Traveler’s Diarrhea Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Global Traveler’s Diarrhea Treatment Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 43. Global Traveler’s Diarrhea Treatment Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 44. Breakdown of Traveler’s Diarrhea Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Traveler’s Diarrhea Treatment Players Head Office, Products and Services Provided
Table 46. Traveler’s Diarrhea Treatment Mergers & Acquisitions in the Past Five Years
Table 47. Traveler’s Diarrhea Treatment New Entrants and Expansion Plans
Table 48. Global Traveler’s Diarrhea Treatment Revenue (USD Million) by Type (2017-2022)
Table 49. Global Traveler’s Diarrhea Treatment Revenue Share by Type (2017-2022)
Table 50. Global Traveler’s Diarrhea Treatment Revenue Forecast by Type (2023-2028)
Table 51. Global Traveler’s Diarrhea Treatment Revenue by Application (2017-2022)
Table 52. Global Traveler’s Diarrhea Treatment Revenue Forecast by Application (2023-2028)
Table 53. North America Traveler’s Diarrhea Treatment Revenue by Type (2017-2022) & (USD Million)
Table 54. North America Traveler’s Diarrhea Treatment Revenue by Type (2023-2028) & (USD Million)
Table 55. North America Traveler’s Diarrhea Treatment Revenue by Application (2017-2022) & (USD Million)
Table 56. North America Traveler’s Diarrhea Treatment Revenue by Application (2023-2028) & (USD Million)
Table 57. North America Traveler’s Diarrhea Treatment Revenue by Country (2017-2022) & (USD Million)
Table 58. North America Traveler’s Diarrhea Treatment Revenue by Country (2023-2028) & (USD Million)
Table 59. Europe Traveler’s Diarrhea Treatment Revenue by Type (2017-2022) & (USD Million)
Table 60. Europe Traveler’s Diarrhea Treatment Revenue by Type (2023-2028) & (USD Million)
Table 61. Europe Traveler’s Diarrhea Treatment Revenue by Application (2017-2022) & (USD Million)
Table 62. Europe Traveler’s Diarrhea Treatment Revenue by Application (2023-2028) & (USD Million)
Table 63. Europe Traveler’s Diarrhea Treatment Revenue by Country (2017-2022) & (USD Million)
Table 64. Europe Traveler’s Diarrhea Treatment Revenue by Country (2023-2028) & (USD Million)
Table 65. Asia-Pacific Traveler’s Diarrhea Treatment Revenue by Type (2017-2022) & (USD Million)
Table 66. Asia-Pacific Traveler’s Diarrhea Treatment Revenue by Type (2023-2028) & (USD Million)
Table 67. Asia-Pacific Traveler’s Diarrhea Treatment Revenue by Application (2017-2022) & (USD Million)
Table 68. Asia-Pacific Traveler’s Diarrhea Treatment Revenue by Application (2023-2028) & (USD Million)
Table 69. Asia-Pacific Traveler’s Diarrhea Treatment Revenue by Region (2017-2022) & (USD Million)
Table 70. Asia-Pacific Traveler’s Diarrhea Treatment Revenue by Region (2023-2028) & (USD Million)
Table 71. South America Traveler’s Diarrhea Treatment Revenue by Type (2017-2022) & (USD Million)
Table 72. South America Traveler’s Diarrhea Treatment Revenue by Type (2023-2028) & (USD Million)
Table 73. South America Traveler’s Diarrhea Treatment Revenue by Application (2017-2022) & (USD Million)
Table 74. South America Traveler’s Diarrhea Treatment Revenue by Application (2023-2028) & (USD Million)
Table 75. South America Traveler’s Diarrhea Treatment Revenue by Country (2017-2022) & (USD Million)
Table 76. South America Traveler’s Diarrhea Treatment Revenue by Country (2023-2028) & (USD Million)
Table 77. Middle East & Africa Traveler’s Diarrhea Treatment Revenue by Type (2017-2022) & (USD Million)
Table 78. Middle East & Africa Traveler’s Diarrhea Treatment Revenue by Type (2023-2028) & (USD Million)
Table 79. Middle East & Africa Traveler’s Diarrhea Treatment Revenue by Application (2017-2022) & (USD Million)
Table 80. Middle East & Africa Traveler’s Diarrhea Treatment Revenue by Application (2023-2028) & (USD Million)
Table 81. Middle East & Africa Traveler’s Diarrhea Treatment Revenue by Country (2017-2022) & (USD Million)
Table 82. Middle East & Africa Traveler’s Diarrhea Treatment Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Traveler’s Diarrhea Treatment Picture
Figure 2. Global Traveler’s Diarrhea Treatment Revenue Market Share by Type in 2021
Figure 3. Immunization
Figure 4. Non-antibiotic Agents
Figure 5. Antibiotics
Figure 6. Anti-Motility Agents
Figure 7. Other
Figure 8. Traveler’s Diarrhea Treatment Revenue Market Share by Application in 2021
Figure 9. Adult Traveler's Diarrhea Picture
Figure 10. Children Traveler's Diarrhea Picture
Figure 11. Global Traveler’s Diarrhea Treatment Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Traveler’s Diarrhea Treatment Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Traveler’s Diarrhea Treatment Revenue Market Share by Region (2017-2028)
Figure 14. Global Traveler’s Diarrhea Treatment Revenue Market Share by Region in 2021
Figure 15. North America Traveler’s Diarrhea Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Traveler’s Diarrhea Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Traveler’s Diarrhea Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Traveler’s Diarrhea Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Traveler’s Diarrhea Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Traveler’s Diarrhea Treatment Market Drivers
Figure 21. Traveler’s Diarrhea Treatment Market Restraints
Figure 22. Traveler’s Diarrhea Treatment Market Trends
Figure 23. Salix Pharmaceuticals Recent Developments and Future Plans
Figure 24. P&G Recent Developments and Future Plans
Figure 25. Johnson & Johnson Recent Developments and Future Plans
Figure 26. Otsuka Pharma Recent Developments and Future Plans
Figure 27. Valneva Recent Developments and Future Plans
Figure 28. Shanghai United Cell Recent Developments and Future Plans
Figure 29. PaxVax Recent Developments and Future Plans
Figure 30. Livzon Recent Developments and Future Plans
Figure 31. Immuron Recent Developments and Future Plans
Figure 32. Global Traveler’s Diarrhea Treatment Revenue Share by Players in 2021
Figure 33. Traveler’s Diarrhea Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 34. Global Top 3 Players Traveler’s Diarrhea Treatment Revenue Market Share in 2021
Figure 35. Global Top 10 Players Traveler’s Diarrhea Treatment Revenue Market Share in 2021
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 37. Global Traveler’s Diarrhea Treatment Revenue Share by Type in 2021
Figure 38. Global Traveler’s Diarrhea Treatment Market Share Forecast by Type (2023-2028)
Figure 39. Global Traveler’s Diarrhea Treatment Revenue Share by Application in 2021
Figure 40. Global Traveler’s Diarrhea Treatment Market Share Forecast by Application (2023-2028)
Figure 41. North America Traveler’s Diarrhea Treatment Sales Market Share by Type (2017-2028)
Figure 42. North America Traveler’s Diarrhea Treatment Sales Market Share by Application (2017-2028)
Figure 43. North America Traveler’s Diarrhea Treatment Revenue Market Share by Country (2017-2028)
Figure 44. United States Traveler’s Diarrhea Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Traveler’s Diarrhea Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Traveler’s Diarrhea Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Traveler’s Diarrhea Treatment Sales Market Share by Type (2017-2028)
Figure 48. Europe Traveler’s Diarrhea Treatment Sales Market Share by Application (2017-2028)
Figure 49. Europe Traveler’s Diarrhea Treatment Revenue Market Share by Country (2017-2028)
Figure 50. Germany Traveler’s Diarrhea Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Traveler’s Diarrhea Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Traveler’s Diarrhea Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Traveler’s Diarrhea Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Traveler’s Diarrhea Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Traveler’s Diarrhea Treatment Sales Market Share by Type (2017-2028)
Figure 56. Asia-Pacific Traveler’s Diarrhea Treatment Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Traveler’s Diarrhea Treatment Revenue Market Share by Region (2017-2028)
Figure 58. China Traveler’s Diarrhea Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Traveler’s Diarrhea Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. South Korea Traveler’s Diarrhea Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Traveler’s Diarrhea Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Traveler’s Diarrhea Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Traveler’s Diarrhea Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Traveler’s Diarrhea Treatment Sales Market Share by Type (2017-2028)
Figure 65. South America Traveler’s Diarrhea Treatment Sales Market Share by Application (2017-2028)
Figure 66. South America Traveler’s Diarrhea Treatment Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Traveler’s Diarrhea Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Traveler’s Diarrhea Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East and Africa Traveler’s Diarrhea Treatment Sales Market Share by Type (2017-2028)
Figure 70. Middle East and Africa Traveler’s Diarrhea Treatment Sales Market Share by Application (2017-2028)
Figure 71. Middle East and Africa Traveler’s Diarrhea Treatment Revenue Market Share by Country (2017-2028)
Figure 72. Turkey Traveler’s Diarrhea Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Traveler’s Diarrhea Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. UAE Traveler’s Diarrhea Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source